| Ident. | Authors (with country if any) | Title |
|---|
| 000176 (2017) |
Sibylle Loibl ; Lorena De La Pena ; Valentina Nekljudova ; Dimitrios Zardavas ; Stefan Michiels ; Carsten Denkert ; Mahdi Rezai ; Bego A Bermejo ; Michael Untch ; Soo Chin Lee ; Sabine Turri ; Patrick Urban ; Sherko Kümmel ; Guenther Steger ; Andrea Gombos ; Michael Lux ; Martine J. Piccart ; Gunter Von Minckwitz ; José Baselga ; Sherene Loi | Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer: A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE). |
| 000181 (2017) |
Federica Grosso ; Nicola Steele ; Silvia Novello ; Anna K. Nowak ; Sanjay Popat ; Laurent Greillier ; Thomas John ; Natasha B. Leighl ; Martin Reck ; Paul Taylor ; David Planchard ; Jens Benn S Rensen ; Mark A. Socinski ; Ute Von Wangenheim ; Arsène Bienvenu Loembé ; José Barrueco ; Nassim Morsli ; Giorgio Scagliotti | Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial. |
| 000224 (2017) |
Julianne Bayliss ; Lilly Yuen ; Gillian Rosenberg ; Darren Wong ; Margaret Littlejohn ; Kathleen Jackson ; Anuj Gaggar ; Kathryn M. Kitrinos ; G Mani Subramanian ; Patrick Marcellin ; Maria Buti ; Harry L A. Janssen ; Ed Gane ; Vitina Sozzi ; Danni Colledge ; Rachel Hammond ; Rosalind Edwards ; Stephen Locarnini ; Alexander Thompson ; Peter A. Revill | Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B. |
| 000408 (2017) |
Jedd D. Wolchok ; Vanna Chiarion-Sileni ; Rene Gonzalez ; Piotr Rutkowski ; Jean-Jacques Grob ; C Lance Cowey ; Christopher D. Lao ; John Wagstaff ; Dirk Schadendorf ; Pier F. Ferrucci ; Michael Smylie ; Reinhard Dummer ; Andrew Hill ; David Hogg ; John Haanen ; Matteo S. Carlino ; Oliver Bechter ; Michele Maio ; Ivan Marquez-Rodas ; Massimo Guidoboni ; Grant Mcarthur ; Celeste Lebbé ; Paolo A. Ascierto ; Georgina V. Long ; Jonathan Cebon ; Jeffrey Sosman ; Michael A. Postow ; Margaret K. Callahan ; Dana Walker ; Linda Rollin ; Rafia Bhore ; F Stephen Hodi ; James Larkin | Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma. |
| 000411 (2017) |
Ramaswamy Govindan ; Aleksandra Szczesna ; Myung-Ju Ahn ; Claus-Peter Schneider ; Pablo Fernando Gonzalez Mella ; Fabrice Barlesi ; Baohui Han ; Doina Elena Ganea ; Joachim Von Pawel ; Vladimir Vladimirov ; Natalia Fadeeva ; Ki Hyeong Lee ; Takayasu Kurata ; Li Zhang ; Tomohide Tamura ; Pieter E. Postmus ; Jacek Jassem ; Kenneth O'Byrne ; Justin Kopit ; Mingshun Li ; Marina Tschaika ; Martin Reck | Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer. |
| 000430 (2017) |
Wissal Ben Jmaa ; Alfredo I. Hernández ; Megan R. Sutherland ; Anik Cloutier ; Nathalie Germain ; Christian Lachance ; Brigitte Martin ; Marc H. Lebel ; Patrick Pladys ; Anne Monique Nuyt | Cardio-respiratory Events and Inflammatory Response After Primary Immunization in Preterm Infants < 32 Weeks Gestational Age: A Randomized Controlled Study. |
| 000521 (2017) |
Götz Thomalla ; Florent Boutitie ; Jochen B. Fiebach ; Claus Z. Simonsen ; Norbert Nighoghossian ; Salvador Pedraza ; Robin Lemmens ; Pascal Roy ; Keith W. Muir ; Christoph Heesen ; Martin Ebinger ; Ian Ford ; Bastian Cheng ; Tae-Hee Cho ; Josep Puig ; Vincent Thijs ; Matthias Endres ; Jens Fiehler ; Christian Gerloff | Effect of informed consent on patient characteristics in a stroke thrombolysis trial. |
| 000529 (2017) |
Eric Pujade-Lauraine ; Jonathan A. Ledermann ; Frédéric Selle ; Val Gebski ; Richard T. Penson ; Amit M. Oza ; Jacob Korach ; Tomasz Huzarski ; Andrés Poveda ; Sandro Pignata ; Michael Friedlander ; Nicoletta Colombo ; Philipp Harter ; Keiichi Fujiwara ; Isabelle Ray-Coquard ; Susana Banerjee ; Joyce Liu ; Elizabeth S. Lowe ; Ralph Bloomfield ; Patricia Pautier | Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial. |
| 000534 (2017) |
Michele Maio ; Arnaud Scherpereel ; Luana Calabr ; Joachim Aerts ; Susana Cedres Perez ; Alessandra Bearz ; Kristiaan Nackaerts ; Dean A. Fennell ; Dariusz Kowalski ; Anne S. Tsao ; Paul Taylor ; Federica Grosso ; Scott J. Antonia ; Anna K. Nowak ; Maria Taboada ; Martina Puglisi ; Paul K. Stockman ; Hedy L. Kindler | Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial. |
| 000640 (2017) |
Dirk Schadendorf ; James Larkin ; Jedd Wolchok ; F Stephen Hodi ; Vanna Chiarion-Sileni ; Rene Gonzalez ; Piotr Rutkowski ; Jean-Jacques Grob ; C Lance Cowey ; Christopher Lao ; John Wagstaff ; Margaret K. Callahan ; Michael A. Postow ; Michael Smylie ; Pier Francesco Ferrucci ; Reinhard Dummer ; Andrew Hill ; Fiona Taylor ; Javier Sabater ; Dana Walker ; Srividya Kotapati ; Amy Abernethy ; Georgina V. Long | Health-related quality of life results from the phase III CheckMate 067 study. |
| 000648 (2017) |
George W. Sledge ; Masakazu Toi ; Patrick Neven ; Joohyuk Sohn ; Kenichi Inoue ; Xavier Pivot ; Olga Burdaeva ; Meena Okera ; Norikazu Masuda ; Peter A. Kaufman ; Han Koh ; Eva-Maria Grischke ; Martin Frenzel ; Yong Lin ; Susana Barriga ; Ian C. Smith ; Nawel Bourayou ; Antonio Llombart-Cussac | MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2- Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy. |
| 000740 (2017) |
Ashish Khanna ; Shane W. English ; Xueyuan S. Wang ; Kealy Ham ; James Tumlin ; Harold Szerlip ; Laurence W. Busse ; Laith Altaweel ; Timothy E. Albertson ; Caleb Mackey ; Michael T. Mccurdy ; David W. Boldt ; Stefan Chock ; Paul J. Young ; Kenneth Krell ; Richard G. Wunderink ; Marlies Ostermann ; Raghavan Murugan ; Michelle N. Gong ; Rakshit Panwar ; Johanna H Stbacka ; Raphael Favory ; Balasubramanian Venkatesh ; B Taylor Thompson ; Rinaldo Bellomo ; Jeffrey Jensen ; Stew Kroll ; Lakhmir S. Chawla ; George F. Tidmarsh ; Adam M. Deane | Angiotensin II for the Treatment of Vasodilatory Shock. |
| 000743 (2017) |
Shaji Kumar ; Philippe Moreau ; Parameswaran Hari ; Maria-Victoria Mateos ; Heinz Ludwig ; Chaim Shustik ; Tamas Masszi ; Andrew Spencer ; Roman Hájek ; Kenneth Romeril ; Irit Avivi ; Anna M. Liberati ; Monique C. Minnema ; Hermann Einsele ; Sagar Lonial ; Deborah Berg ; Jianchang Lin ; Neeraj Gupta ; Dixie-Lee Esseltine ; Paul G. Richardson | Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma. |
| 000949 (2017) |
Rahel Wampfler ; Natalie E. Hofmann ; Stephan Karl ; Inoni Betuela ; Benson Kinboro ; Lina Lorry ; Mariabeth Silkey ; Leanne J. Robinson ; Ivo Mueller ; Ingrid Felger | Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum. |
| 000A33 (2017) |
Steven L. Goldberg ; Ian Meredith ; Thomas Marwick ; Brian A. Haluska ; Janusz Lipiecki ; Tomasz Siminiak ; Nawzer Mehta ; David M. Kaye ; Horst Sievert | A randomized double-blind trial of an interventional device treatment of functional mitral regurgitation in patients with symptomatic congestive heart failure-Trial design of the REDUCE FMR study. |
| 000B26 (2017) |
Peter Nash ; Bruce Kirkham ; Masato Okada ; Proton Rahman ; Benard Combe ; Gerd-Ruediger Burmester ; David H. Adams ; Lisa Kerr ; Chin Lee ; Catherine L. Shuler ; Mark Genovese | Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial. |
| 000B38 (2017) |
Andrew Blauvelt ; Marjolein De Bruin-Weller ; Melinda Gooderham ; Jennifer C. Cather ; Jamie Weisman ; David Pariser ; Eric L. Simpson ; Kim A. Papp ; H Chih-Ho Hong ; Diana Rubel ; Peter Foley ; Errol Prens ; Christopher E M. Griffiths ; Takafumi Etoh ; Pedro Herranz Pinto ; Ramon M. Pujol ; Jacek C. Szepietowski ; Karel Ettler ; Lajos Kemény ; Xiaoping Zhu ; Bolanle Akinlade ; Thomas Hultsch ; Vera Mastey ; Abhijit Gadkari ; Laurent Eckert ; Nikhil Amin ; Neil M H. Graham ; Gianluca Pirozzi ; Neil Stahl ; George D. Yancopoulos ; Brad Shumel | Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. |
| 000B53 (2017) |
Kim Papp ; Herve Bachelez ; Antonio Costanzo ; Peter Foley ; Melinda Gooderham ; Primal Kaur ; Joanna Narbutt ; Sandra Philipp ; Lynda Spelman ; Jolanta Weglowska ; Nan Zhang ; Bruce Strober | Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study. |
| 000D14 (2017) |
Paolo A. Ascierto ; Michele Del Vecchio ; Caroline Robert ; Andrzej Mackiewicz ; Vanna Chiarion-Sileni ; Ana Arance ; Céleste Lebbé ; Lars Bastholt ; Omid Hamid ; Piotr Rutkowski ; Catriona Mcneil ; Claus Garbe ; Carmen Loquai ; Brigitte Dreno ; Luc Thomas ; Jean-Jacques Grob ; Gabriella Liszkay ; Marta Nyakas ; Ralf Gutzmer ; Joanna Pikiel ; Florent Grange ; Christoph Hoeller ; Virginia Ferraresi ; Michael Smylie ; Dirk Schadendorf ; Laurent Mortier ; Inge Marie Svane ; Delphine Hennicken ; Anila Qureshi ; Michele Maio | Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial. |
| 000D89 (2017) |
Robert I. Haddad ; Martin Schlumberger ; Lori J. Wirth ; Eric J. Sherman ; Manisha H. Shah ; Bruce Robinson ; Corina E. Dutcus ; Angela Teng ; Andrew G. Gianoukakis ; Steven I. Sherman | Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes. |
| 000E46 (2017) |
Signe Borgquist ; Anita Giobbie-Hurder ; Thomas P. Ahern ; Judy E. Garber ; Marco Colleoni ; István Láng ; Marc Debled ; Bent Ejlertsen ; Roger Von Moos ; Ian Smith ; Alan S. Coates ; Aron Goldhirsch ; Manuela Rabaglio ; Karen N. Price ; Richard D. Gelber ; Meredith M. Regan ; Beat Thürlimann | Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study. |
